Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Stanfield

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Frontiers in Immunology|December 26, 2022
The CMV-encoded G protein-coupled receptors M33 and US28 play pleiotropic roles in immune evasion and alter host T cell responsesTimothy M White, Cassandra M Bonavita, Brent A Stanfield, et al.
BMC Cancer|November 26, 2022
Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitorsManali Singha, Limeng Pu, Brent A Stanfield, et al.
The Journal of Biological Chemistry|February 16, 1996
Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIaP J Larson, S A Stanfield-Oakley, W J VanDusen, et al.
Plos One|October 29, 2014
A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strainsBrent A Stanfield, Jacque Stahl, Vladimir N Chouljenko, et al.
Vaccines|June 11, 2020
CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell ResponsesPhoebe E Lewis, Ethan C Poteet, Dongliang Liu, et al.
Journal of Virology|April 14, 2017
Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in MiceShiliang A Liu, Brent A Stanfield, Vladimir N Chouljenko, et al.
Cancers|August 26, 2023
Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in CancerManali Singha, Limeng Pu, Gopal Srivastava, et al.
Plos One|February 7, 2020
Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesisShan K Naidu, Rafiq Nabi, Nagarjuna R Cheemarla, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1989
Single-dose cefmetazole versus multiple dose cefoxitin for prophylaxis in abdominal surgeryJ T DiPiro, L S Welage, B A Levine, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41L Xu, A Pozniak, A Wildfire, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Frontiers in Immunology|December 26, 2022
The CMV-encoded G protein-coupled receptors M33 and US28 play pleiotropic roles in immune evasion and alter host T cell responsesTimothy M White, Cassandra M Bonavita, Brent A Stanfield, et al.
BMC Cancer|November 26, 2022
Artificial intelligence to guide precision anticancer therapy with multitargeted kinase inhibitorsManali Singha, Limeng Pu, Brent A Stanfield, et al.
The Journal of Biological Chemistry|February 16, 1996
Structural integrity of the gamma-carboxyglutamic acid domain of human blood coagulation factor IXa Is required for its binding to cofactor VIIIaP J Larson, S A Stanfield-Oakley, W J VanDusen, et al.
Plos One|October 29, 2014
A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strainsBrent A Stanfield, Jacque Stahl, Vladimir N Chouljenko, et al.
Vaccines|June 11, 2020
CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell ResponsesPhoebe E Lewis, Ethan C Poteet, Dongliang Liu, et al.
Journal of Virology|April 14, 2017
Intramuscular Immunization of Mice with the Live-Attenuated Herpes Simplex Virus 1 Vaccine Strain VC2 Expressing Equine Herpesvirus 1 (EHV-1) Glycoprotein D Generates Anti-EHV-1 Immune Responses in MiceShiliang A Liu, Brent A Stanfield, Vladimir N Chouljenko, et al.
Cancers|August 26, 2023
Unlocking the Potential of Kinase Targets in Cancer: Insights from CancerOmicsNet, an AI-Driven Approach to Drug Response Prediction in CancerManali Singha, Limeng Pu, Gopal Srivastava, et al.
Plos One|February 7, 2020
Intramuscular vaccination of mice with the human herpes simplex virus type-1(HSV-1) VC2 vaccine, but not its parental strain HSV-1(F) confers full protection against lethal ocular HSV-1 (McKrae) pathogenesisShan K Naidu, Rafiq Nabi, Nagarjuna R Cheemarla, et al.
The Journal of Antimicrobial Chemotherapy|April 1, 1989
Single-dose cefmetazole versus multiple dose cefoxitin for prophylaxis in abdominal surgeryJ T DiPiro, L S Welage, B A Levine, et al.
Antimicrobial Agents and Chemotherapy|February 25, 2005
Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41L Xu, A Pozniak, A Wildfire, et al.
Pageof 5